Amy Freyman
Impact in
Papers in
- Oncology 10
- HER2/EGFR in Cancer Research 9
- Cancer Treatment and Pharmacology 3
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- Charles Zacharchuk (4 shared papers)Benjamin Besse (1 shared paper)Thomas J. Lynch (1 shared paper)Christine Powell (1 shared paper)Jean‐Charles Soria (1 shared paper)Keith D. Eaton (1 shared paper)Susan Quinn (1 shared paper)Barbara J. Gitlitz (1 shared paper)
- Journals
- Cancer Research (3 papers)British Journal of Cancer (2 papers)Journal of Clinical Oncology (2 papers)mAbs (1 paper)The Lancet (1 paper)
- Partner nations
- United StatesUkraineChina
In The Last Decade
Amy Freyman
12 papers receiving 641 citations
Amy Freyman's Hit Papers
Peers
Comparison fields: 5 of 45
- Oncology 418
- Urology 98
- Pulmonary and Respiratory Medicine 326
- Dermatology 71
- Genetics 52
Countries citing papers authored by Amy Freyman
This map shows the geographic impact of Amy Freyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Freyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Freyman more than expected).
Fields of papers citing papers by Amy Freyman
This network shows the impact of papers produced by Amy Freyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Freyman. The network helps show where Amy Freyman may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Freyman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 357 | |
| 2 | Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial Hit paper breakdown → | 2023 | 134 |
| 3 | 2013 | 70 | |
| 4 | 2018 | 50 | |
| 5 | 2009 | 14 | |
| 6 | 2017 | 13 | |
| 7 | 2010 | 7 | |
| 8 | 2023 | 4 | |
| 9 | 2011 | 3 | |
| 10 | 2016 | 2 | |
| 11 | 2020 | 2 | |
| 12 | 2021 | 1 |
About Amy Freyman
Amy Freyman is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 12 papers that have together received 657 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Cancer Treatment and Pharmacology (3 papers), Advanced Breast Cancer Therapies (3 papers), Biosimilars and Bioanalytical Methods (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Hair Growth and Disorders (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Oncology (418 citations), Urology (98 citations), Pulmonary and Respiratory Medicine (326 citations), Dermatology (71 citations) and Genetics (52 citations). Amy Freyman has collaborated with scholars based in United States, Ukraine and China. Frequent co-authors include Charles Zacharchuk, Benjamin Besse, Thomas J. Lynch, Christine Powell, Jean‐Charles Soria, Keith D. Eaton, Susan Quinn, Barbara J. Gitlitz, Lecia V. Sequist and Vincent A. Miller. Their work appears in journals such as Cancer Research, British Journal of Cancer, Journal of Clinical Oncology, mAbs and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.